The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway.
about
Prostate cancer relevant antigens and enzymes for targeted drug deliveryLeuprorelin acetate long-lasting effects on GnRH receptors of prostate cancer cells: an atomic force microscopy study of agonist/receptor interactionGonadotropin-releasing hormone agonists sensitize, and resensitize, prostate cancer cells to docetaxel in a p53-dependent mannerDiversity of actions of GnRHs mediated by ligand-induced selective signalingA phenotypic high throughput screening assay for the identification of pharmacoperones for the gonadotropin releasing hormone receptorGonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signaling.Odors activate dual pathways, a TRPC2 and a AA-dependent pathway, in mouse vomeronasal neurons.Chaperoning G protein-coupled receptors: from cell biology to therapeuticsGonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH).Ability of luteinizing hormone releasing hormone-Pseudomonas aeruginosa exotoxin 40 binding to LHRH receptor on human liver cancer cells.Luteinizing hormone-releasing hormone I (LHRH-I) and its metabolite in peripheral tissues.Augmentation of gonadotropin-releasing hormone receptor expression in the post-lactational mammary tissues of rats.New agonist- and antagonist-based treatment approaches for advanced prostate cancer.Synthesis, characterization and systematic comparison of FITC-labelled GnRH-I, -II and -III analogues on various tumour cells.Differential signaling of the GnRH receptor in pituitary gonadotrope cell lines and prostate cancer cell lines.The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and MetastasisA novel indium-111-labeled gonadotropin-releasing hormone peptide for human prostate cancer imaging.Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer.Inhibitory effects of a luteinizing hormone-releasing hormone agonist on basal and epidermal growth factor-induced cell proliferation and metastasis-associated properties in human epidermoid carcinoma A431 cells.
P2860
Q27013843-5BE06683-6029-4606-8B88-BCB148208950Q28484928-9F91DDDE-5F94-4D84-92F0-BCF16B51C00FQ28537723-97AFABAE-AB1C-471B-BFF4-5AD715021EB7Q30439870-85191B72-5BBB-424B-B363-E26F4659D3F1Q33629937-9A97DFEE-B608-4B90-8310-38E5C6C01BFBQ33642701-9830EC8A-E8A1-4144-ADBF-161DAE806EBAQ33840419-8246D715-0163-4995-9DE1-E5E94D8071ADQ33927508-FAE0D676-052D-4F3C-B3DE-6B0CC6913597Q34486740-E3090454-76E4-48B5-9726-F056DFF8588FQ35089850-08DE62CE-501A-4036-AD8F-33F5249E90FFQ36065616-D386F723-6B5F-4AA0-B579-9C1D4F3D4B1DQ37068413-BE721FBC-3F4C-491C-9910-8604F11340A5Q37369730-352DD04B-5393-4CC8-9F47-A2735ABD189FQ38042768-4839A43B-8377-4BCD-B0A0-397095DC3C93Q38756598-05B7ADD5-056E-461D-897D-E45178D71152Q39199813-02821710-B563-435B-AC21-8A3F3EB2003AQ41242658-1B4A86A1-3F15-4D60-BE58-E114AB4FB6B0Q42137476-928788D3-7BC1-4711-B770-E6A78E9B77EDQ42364477-9101835E-A877-439C-A0A9-B9783C77773CQ42520968-ECB1BC2F-6769-4FF9-B9A7-4026B40A287C
P2860
The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
The luteinizing hormone-releas ...... d signal transduction pathway.
@en
type
label
The luteinizing hormone-releas ...... d signal transduction pathway.
@en
prefLabel
The luteinizing hormone-releas ...... d signal transduction pathway.
@en
P2093
P356
P1433
P1476
The luteinizing hormone-releas ...... d signal transduction pathway.
@en
P2093
P304
P356
10.1210/ENDO.140.11.7087
P407
P577
1999-11-01T00:00:00Z